Postoperative spondylodiskitis due to stomatococcus mucilaginosus in an immunocompetent patient

Scandinavian Journal of Infectious Diseases

Volumn 35, Issue 2, 2003, Pages 146-147

  Bureau Chalot, Florence ^a   Piednoir, Emmanuel ^a   Bazin, Arnaud ^b   Brasme, Lucien ^a   Bajolet, Odile ^a  

^a SERVICE DE DERMATOLOGIE   (France)

^b HÔPITAL MAISON BLANCHE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

BETA LACTAM ANTIBIOTIC; CEFOTAXIME; FOSFOMYCIN; FUSIDIC ACID; GLYCOPEPTIDE; OXACILLIN; PRISTINAMYCIN; QUINOLINE DERIVED ANTIINFECTIVE AGENT; RIFAMPICIN; SISOMICIN;

ADULT; ANTIBIOTIC SENSITIVITY; ARTICLE; BLOOD CULTURE; BONE BIOPSY; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; DISEASE SEVERITY; FEMALE; HOSPITAL ADMISSION; HOSPITAL DISCHARGE; HUMAN; IMMUNOCOMPETENCE; INTERVERTEBRAL DISK HERNIA; INTERVERTEBRAL DISKECTOMY; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOGENESIS; POSTOPERATIVE INFECTION; POSTOPERATIVE PAIN; ROTHIA; SPINE RADIOGRAPHY; SPONDYLITIS; TREATMENT OUTCOME;

ADULT; ANTI-BACTERIAL AGENTS; DISCITIS; DRUG THERAPY, COMBINATION; FEMALE; FOLLOW-UP STUDIES; GRAM-POSITIVE BACTERIAL INFECTIONS; GRAM-POSITIVE COCCI; HUMANS; IMMUNOCOMPETENCE; LUMBAR VERTEBRAE; MICROBIAL SENSITIVITY TESTS; ORTHOPEDIC PROCEDURES; POSTOPERATIVE COMPLICATIONS; RISK ASSESSMENT; SPINAL DISEASES; TREATMENT OUTCOME;

EID: 0037241195     PISSN: 00365548     EISSN: None     Source Type: Journal    
DOI: 10.1080/0036554021000027022     Document Type: Article

References (9)

1. Jiménez-Mejias ME, de Dios Colmenero J, Sánchez-Lora J, Palomino-Nicás J, Reguera JM, Garcia de la Heras J, et al. Postoperative spondylodiskitis: etiology, clinical findings, prognosis, and comparison with nonoperative pyogenic, spondylodiskitis. Clin Infect Dis 1999; 29: 339-45.
2. Collins MD, Hutson RA, Båverud V, Falsen E. Characterization of a Rothia-like organism from a mouse: description of Rothia nasimurium sp. nov. and reclassification of Stomatococcus mucilaginosus as Rothia mucilaginosa comb. nov. Int J Syst Evol Microbiol 2000; 50: 1247-51.
3. Bergan T, Kocur M. Stomatococcus mucilaginosus gen.nov., sp.nov., ep. Rev., a member of the family Micrococcaceae. Int J Syst Bacteriol 1982; 32: 374-7.
4. McWhinney PHM, Kibber CC, Gillespie SH, Patel S, Morrison D, Hoffbrand AV, Prentice HG. Stomatococcus mucilaginosus: an emerging pathogen in neutropenic patients. Clin Infect Dis 1992; 14: 641-6.
5. Ascher DP, Zbick C, White C, Fischer GW. Infections due to Stomatococcus mucilaginosus: 10 cases and review. Rev Infect Dis 1991; 13: 1048-52.
6. Harjola VP, Valtonen M, Sivonen A. Association of Stomatococcus mucilaginosus with cholangitis. Eur J Clin Microbiol Infect Dis 1994; 13: 606-8.
7. Nielsen H. Vertebral osteomyelitis with Stomatococcus mucilaginosus. Eur J Clin Microbiol Infect Dis 1994; 13: 775-6.
8. Tan R, White V, Servais G, Bryce EA. Postoperative endophthalmitis caused by Stomatococcus mucilaginosus. Clin Infect Dis 1994; 18: 492-3.
9. Von Eiff C, Herrmann M, Peters G. Antimicrobial susceptibilities of Stomatococcus mucilaginosus and of Micrococcus spp. Antimicrob Agents Chemother 1995; 39: 268-70.